December 2007
AvantiCell Science Ltd has secured capital investment from Barwell plc to develop its cell culture-based service and product business. Barwell’s investment is matched by the Scottish Enterprise Co-Investment fund, and creates a platform for launch of the company’s range of cell-based assay kits, underpinned by the establishment of clean-room manufacturing facilities and complemented by dedicated marketing and sales expertise.

October 2007
AvantiCell Science Ltd has signed a Collaboration Agreement with the University of Malaya to develop new methods that will test the activity and safety of traditional medicines. The signing of the Collaboration Agreement marks the beginning of an exciting working relationship in which AvantiCell’s technology will be used to mine the enormous biodiversity of Malaysia’s rain-forests to identify new therapeutic agents.

August 2007
A consortium of three Ayrshire companies led by AvantiCell Science has begun a project, with investment from the UK Technology Strategy Board, to build the next generation of tools for use in the discovery of new drugs. The consortium, which includes biomaterials specialists Giltech Ltd and Culzean Medical Devices Ltd, will create a new generation of three-dimensional cell-based assays for use in drug discovery. The project will run for 2 years, with the partners and the Technology Strategy Board together investing £0.9M.

February 2007
Avanticell Science attend Screening Europe 2007 Conference. AvantiCell will be represented at the forthcoming Screening Europe Conference on 20-21 February in Barcelona, Spain. To meet with our representative during the Conference, please contact us at info@avanticell.com

January 2007
AvantiCell Science launches novel bovine mammary cell culture system for study of transport of drugs, and environmental agents into cow’s milk.
>>download data sheet<<

December 2006
AvantiCell Science secures funding for Research & Development Project with Chinese government institute to apply cell-based analysis to Traditional Chinese Medicines

November 2006
AvantiCell Science, in partnership with two other businesses, secures major DTI Technology Programme award to screen and develop novel toxins from marine microbes

October 2006
AvantiCell Science secures major contract to develop customised cell culture system for study of xenobiotic transport and metabolism

September 2006
AvantiCell Science launches cell-based assay services for evaluation of potential breast cancer therapeutics

E-mail this page to a Colleague